Patents by Inventor Ambrus Toth

Ambrus Toth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7709216
    Abstract: Provided herein are methods relating to inhibition of PUMA function for preventing or reducing myocardial cell death. A method for preventing or reducing ischemia/reperfusion induced myocardial cell death in a human is provided as are methods for identifying pharmaceuticals which interfere with PUMA function. Also herein provided is a method for reducing stem cell death in stem cell explants wherein the explants are intended to restore cardiac efficiency following cell death in response to coronary infarct.
    Type: Grant
    Filed: August 8, 2007
    Date of Patent: May 4, 2010
    Assignee: Boston Biomedical Research Institute
    Inventors: Peter Erhardt, Ambrus Toth
  • Publication number: 20080009030
    Abstract: Provided herein are methods relating to inhibition of PUMA function for preventing or reducing myocardial cell death. A method for preventing or reducing ischemia/reperfusion induced myocardial cell death in a human is provided as are methods for identifying pharmaceuticals which interfere with PUMA function. Also herein provided is a method for reducing stem cell death in stem cell explants wherein the explants are intended to restore cardiac efficiency following cell death in response to coronary infarct.
    Type: Application
    Filed: August 8, 2007
    Publication date: January 10, 2008
    Applicant: Boston Biomedical Research Institute
    Inventors: Peter Erhardt, Ambrus Toth
  • Publication number: 20050250724
    Abstract: Provided herein are methods relating to inhibition of PUMA function for preventing or reducing myocardial cell death. A method for preventing or reducing ischemia/reperfusion induced myocardial cell death in a human is provided as are methods for identifying pharmaceuticals which interfere with PUMA function. Also herein provided is a method for reducing stem cell death in stem cell explants wherein the explants are intended to restore cardiac efficiency following cell death in response to coronary infarct.
    Type: Application
    Filed: April 12, 2005
    Publication date: November 10, 2005
    Inventors: Peter Erhardt, Ambrus Toth